Jyong Biotech Ltd. (MENS)
$2.10+0.00%Close
SELLRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $160M
- Beta
- 2.38
- P/E (TTM)
- -23.35
- Short % float
- 0.79%
- Days to cover
- 4.0
- SI change
- -9.5%
- 1W
- +2.44%
- 1M
- +5.53%
- vs SPY 1W
- +2.02%
- vs SPY 1M
- +3.47%
Industry peers
FMP comparable companies · ranked by market cap
- APGEBUYApogee Therapeutics, Inc.$8.4BBULLQ 60$135.07-0.01%
- CNTACentessa Pharmaceuticals plc$6.3B$40.50
- CGONSELLCG Oncology Inc.$5.6BCRISISQ 25$63.13-1.08%
- TVTXSELLTravere Therapeutics, Inc.$4.8BCRISISQ 33$52.02-0.21%
- XENESELLXenon Pharmaceuticals Inc.$3.5BCRISISQ 22$35.81-1.73%
- LEGNSELLLegend Biotech Corporation$3.3BRECOVERYQ 2$17.80-4.40%
- CELCSELLCelcuity Inc.$3.2BCRISISQ 26$65.85-3.08%
- DYNSELLDyne Therapeutics, Inc.$3.0BRECOVERYQ 3$15.96-4.09%
- RAREBUYUltragenyx Pharmaceutical Inc.$1.5BRECOVERYQ -6$15.30-1.16%
- AAPGSELLAscentage Pharma Group International$1.4BRECOVERYQ 5$15.31+3.80%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on MENS?
- LOPJLB’s latest quantitative signal on Jyong Biotech Ltd. Ordinary Shares (MENS) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is MENS in?
- Jyong Biotech Ltd. Ordinary Shares (MENS) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Jyong Biotech Ltd. Ordinary Shares (MENS) do?
- Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and Genvace. The company is actively advancing a robust pipeline of drug candidate…